Latest Insider Transactions at Qualigen Therapeutics, Inc. (QLGN)
This section provides a real-time view of insider transactions for Qualigen Therapeutics, Inc. (QLGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Qualigen Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Qualigen Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2022
|
Michael S. Poirier Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+13.09%
|
$0
$0.57 P/Share
|
|
Jun 14
2022
|
Amy S. Broidrick President/CSO |
BUY
Open market or private purchase
|
Direct |
30,000
+46.51%
|
$0
$0.62 P/Share
|
|
Aug 19
2021
|
Kurt H Kruger Director |
BUY
Open market or private purchase
|
Direct |
8,000
+20.2%
|
$8,000
$1.23 P/Share
|
|
Apr 26
2021
|
Amy S. Broidrick President/CSO |
BUY
Open market or private purchase
|
Direct |
4,500
+50.0%
|
$9,000
$2.03 P/Share
|
|
Apr 20
2021
|
Michael S. Poirier Chairman and CEO |
BUY
Open market or private purchase
|
Indirect |
11,005
+50.0%
|
$11,005
$1.8 P/Share
|
|
Apr 16
2021
|
Christopher L. Lotz Vice President of Finance, CFO |
BUY
Open market or private purchase
|
Direct |
2,700
+17.72%
|
$2,700
$1.86 P/Share
|
|
Dec 29
2020
|
Kurt H Kruger Director |
BUY
Open market or private purchase
|
Direct |
4,000
+28.57%
|
$8,000
$2.94 P/Share
|
|
Nov 23
2020
|
Kurt H Kruger Director |
BUY
Open market or private purchase
|
Direct |
4,600
+43.4%
|
$13,800
$3.46 P/Share
|
|
Nov 20
2020
|
Kurt H Kruger Director |
BUY
Open market or private purchase
|
Direct |
1,400
+50.0%
|
$4,200
$3.55 P/Share
|